Therefore, to determine the impact of BAP1 inhibition on the protein stability of ASXL1-3, we treated three different SCLC cell lines, NCI-H1963, NCI-H748, and NCI-H1882 cells with varying concentrations of iBAP-II for 24 h. Here, ASXL1 is linked to small cell lung carcinoma.